References
- Gonzalez A, Maradit KH, Crowson CS, et al. The widening mortality gap between rheumatoid arthritis patients and the general population. Arthritis Rheum. 2007;56:3583–3587.
- Choy E. Understanding the dynamics: pathways involved in the pathogenesis of rheumatoid arthritis. Rheumatology. 2012;51:3–11.
- Rossini M, Rossi E, Bernardi D, et al. Prevalence and incidence of rheumatoid arthritis in Italy. Rheumatol Int. 2014;34:659–2974-6.
- Slimani S, Ladjouze-Rezig A. Prevalence of rheumatoid arthritis in an urban population of Algeria: a prospective study. Rheumatology Oxford J. 2014;53:571-573.
- Corbacho M, Dapueto J. Assessing the functional status and quality of life of patients with rheumatoid arthritis. Rev Bras Reumatol. 2010;50:31–43. voln.
- Gamal RM, Mahran SA, Abo E, Fetoh N, et al.Quality of life assessment in Egyptian rheumatoid arthritis patients: relation to clinical features and disease activity. The Egy Rheum. 2016;38:65–70. 10.1016/j.ejr.2015.04.002.
- Wang L, Quan Y, Yue Y, et al. Interleukin-37: a crucial cytokine with multiple roles in disease and potentially clinical therapy. Oncol Lett. 2018;15:4711–4719.
- Nold MF, Nold-Petry CA, Zepp JA, et al. IL-37 is a fundamental inhibitor of innate immunity. Nat Immunol. 2010;11:1014–1022.
- Xia T, Zheng X, Qian B, et al. Plasma interleukin-37 is elevated in patients with rheumatoid arthritis: its correlation with disease activity and Th1/Th2/Th17-related cytokines. Dis Markers. 2015;2015:795043.
- Rahman P, Sun S, Peddle L, et al. Association between the interleukin-1 family gene cluster and psoriatic arthritis. Arthritis Rheum. 2006;54:2321–2325.
- Yin D, Naji DH, Xia Y, et al. Genomic variant in IL-37 confers a significant risk of coronary artery disease. Sci Rep. 2017;7:42175.
- Tan H, Deng B, Yu H, et al. Genetic analysis of innate immunity in Behcet's disease identifies an association with IL-37 and IL-18RAP. Sci Rep. 2016;6:35802. Epub 2016 Oct 24.
- Pei B, Xu S, Liu T, et al. Associations of the IL-1F7 gene polymorphisms with rheumatoid arthritis in Chinese Han population. Int J Immunogenet. 2013;40:199–203.
- Shi L, He Y, Liu Z. Correlation between single nucleotide polymorphism of rs3811047 in IL-1 F7 gene and rheumatoid arthritis susceptibility among Han population in central plains of China. Asian Pacific Jor of Trop Med. 2013;6:73–75.
- Aletaha D, Neogi T, Silman A, et al. 2010 Rheumatoid arthritis classification criteria: an American College of Rheumatology/European League against Rheumatism collaborative initiative . Arthritis Rheum. 2010;62:2569–2581.
- Van der Heijde D, van 't Hof M, van Riel P, et al. Judging disease activity in clinical practice in rheumatoid arthritis: first step in the development of a disease activity score. Ann Rheum Dis. 1990;49:916–920.
- Toraih EA, Ismail NM, Toraih AA, et al. Precursor miR-499a variant but not miR-196a2 is associated with rheumatoid arthritis susceptibility in an Egyptian population. Mol Diagn Ther. 2016;20:279–295.
- Toraih EA, Fawzy MS, Mohammed EA, et al. MicroRNA-196a2 biomarker and targetome network analysis in solid tumors. Mol Diagn Ther. 2016;20:559–577.
- Scott D, Wolfe F, Huizinga T. Rheumatoid arthritis. Lancet. 2010;376:1094–1108.
- Kurkó J, Besenyei T, Laki J, et al. Genetics of rheumatoid arthritis — a comprehensive review. Clinic Rev Allerg Immunol. 2013;45:170–179.
- Conti P, Ronconi G, Caraffa A, et al. IL-37 a new IL-1 family member emerges as a key suppressor of asthma mediated by mast cells. Immunol Invest. 2017;46:239–250.
- Bufler P, Gamboni-Robertson F, Azam T, et al. Interleukin-1 homologues IL- 1F7b and IL-18 contain functional mRNA instability elements within the coding region responsive to lipopolysaccharide. Biochem J. 2004;381:503–510.
- Brennan FM, Feldmann M. Cytokines in autoimmunity. Curr Opin Immunol. 1992;4:754–759.
- Ye L, Jiang B, Deng J, et al.IL-37 alleviates rheumatoid arthritis by suppressing IL-17 and IL-17-triggering cytokine production and limiting th 17 cell proliferation. J Immunol. 2015;194:5110–5119.
- Hu D. Role of anti-inflammatory cytokines IL-35 and IL-37 in asthma. Inflammation. 2017;40:697–707.
- Boraschi D, Lucchesi D, Hainzl S, et al. IL-37: a new anti-inflammatory cytokine of the IL-1 family. Eur Cytokine Netw. 2011;22:127–147.
- Zhao P-W, Jiang W-G, Wang L, et al. Plasma levels of IL-37 and correlation with TNF-α, IL-17A, and disease activity during DMARD treatment of rheumatoid arthritis.. PLoS ONE. 2014;9:e95346. doi:10.1371/journal.pone.0095346.
- Pan F, Liao F, Xia G, et al. Association of IL-1F7 gene with susceptibility to human leukocyte antigen-B27 positive ankylosing spondylitis in Han Chinese population. Clin Chim Acta. 2010;411:124–126.
- Wang X, Yin J, Zheng L, et al. The variant interleukin 1f7 rs3811047 G > A was associated with a decreased risk of gastric cardiac adenocarcinoma in a Chinese Han population. Tumor Biol. 2014;35:3509–3515.